A randomized, controlled, multicenter clinical trial of Fruquintinib combined with TAS-102 with Fruquintinib in the treatment of advanced metastatic colorectal cancer with standard treatment failure

ABSTRACT: Interventions: Experimental group:Give fruquintinib combined with TAS-102;Control Group:fruquintinib Primary outcome(s): Progression-free survival Study Design: Parallel

DISEASE(S): Colorectal Cancer

PROVIDER: 2707127 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR